Synonyms: Epclusa® (sofosbuvir + velpatasvir) | GS-5816 | GS5816 | Vosevi® (sofosbuvir + velpatasvir + voxilaprevi)
velpatasvir is an approved drug (EMA & FDA (2016))
Compound class:
Synthetic organic
Comment: Velpatasvir is a direct-acting inhibitor of hepatitis C virus (HCV) non-structural protein 5A (NS5A) replication complex [2]. It targets viral RNA replication and viron assembly.
|
|
Bioactivity Comments |
Has activity against HCV genotypes 1-6 [2]. |